Released On 27 May February 2015: Injectable Drug Delivery

European Injectable Drug Delivery Market By Formulations [Liposomes,
Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable &

Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes &
Oncology] - Forecasts to 2017
Released On 27th May February 2015
The European injectable drug delivery technologies market was valued at $6.8 billion in 2012, and is
expected to reach $12.4 billion by 2017 at a CAGR of 12.7% from 2012 to 2017. Injectable drug delivery
technologies are a combination of two major segments - devices and formulations. The European injectable
drug delivery formulations technologies market is the largest segment in the market. This is due to a surge
of biologics and development of nanotechnologies. In addition, the market is segmented on the basis of its
therapeutic applications. In the therapeutic field, hormonal disorders command the major segment due to
the high demand of injectable in the treatment of diabetes.
The growth of the injectable drug delivery technologies market is primarily triggered by favorable
reimbursement policies on injectable drugs and devices, technological advancements, surge of biologics in
pharmaceutical markets, rising incidences of cancer and diabetes in Europe, and improving patient
compliance. The evolving opportunities in this market for manufacturers include development of
biosimilars in pharmaceutical markets and focus of pharmaceutical manufacturers towards emerging
markets such as Spain, Russia, Denmark, Ireland and others. However, factors such as needle-stick injuries
and infections and development of alternate delivery methods are restraining the growth of the market.
Germany accounted for the largest market share of the European injectable drug delivery technologies
market in 2012, followed by France. While Germany is a mature market experiencing a surge in biologics
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650 / +91 - 998 729 5242
Published by- http:/www.jsbmarketresearch.com/
and high incidence of chronic diseases, France is the fastest-growing region. This is due to high insurance
coverage for injectable devices and formulations, affordability for healthcare expenses, and activities such
as exhibitions and conferences hosted by France that address injectable drug delivery technologies. The
other European regions of Spain, Italy and Russia show high export potential for plastic syringes and
needle, rising support for generics market, and increasing expenditure in the healthcare sector. The regions
of Switzerland, Denmark, Ireland, Greece, Hungary, the Netherlands, Poland, Portugal, Romania, and
Ukraine provide benefits such as favorable environment for research and development, growth in diabetic
expenditures, and favorable reimbursement policies for injectable devices.
The key players in this market are Becton Dickinson & Co. (U.S.), Baxter International, Inc. (U.S.), Novo
Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Eli Lily & Co. (U.S.), Gerresheimer AG
(Germany), Sanofi (France), West Pharmaceutical Services, Inc. (U.S.), Haselmeier GmbH (Germany), and
Owen Mumford, Ltd. (U.K.).
Scope of the Report
This research report categorizes the European injectable drug delivery technologies market into two
segments, namely, Europe injectable drug delivery devices technologies and European injectable drug
delivery formulations technologies. These markets are broken down into segments and sub-segments,
providing value analysis for 2010, 2011, and 2012, as well as forecast up to 2017. Each market is
comprehensively analyzed by geography (Germany, France, U.K., Spain, Italy, Russia and Rest of Europe
(RoE)) to provide in-depth information on the European scenario.
Browse complete Report on:

http://www.jsbmarketresearch.com/healthcare-medical/r-european-injectable-drugdelivery-market-by-formulations-devices-173996
Europe Injectable Drug Delivery Technologies Market, By Segment

Injectable Drug Delivery Devices Technologies
Injectable Drug Delivery Formulations Technologies

Tel No- 91 2241236650 / +91 - 998 729 5242
Europe Injectable Drug Delivery Devices Technologies Market, By Product

Conventional Injection Devices
By Materials
Glass
Plastics
By Products
Fillable Syringes
Prefilled Syringes
By Usability
Reusable
Disposable
Self-Injection Devices
Needle Free Injectors
By Product
Fillable Syringes
Prefilled Syringes
By Technology
Jet-based Needle Free Injectors
Spring-based Needle Free Injectors
Laser Powered Needle Free Injectors

Tel No- 91 2241236650 / +91 - 998 729 5242
Others
By Usability
Reusable
Disposable
Auto Injectors
By Products
Fillable Syringes
Prefilled Syringes
By Technology
Manual Injection Auto Injectors
Automated Injection Auto Injectors
By Design
Standardized Auto Injectors
Customized Auto Injectors
By Usability
Reusable
Disposable
Pen Injectors
By Products
Single Chambered Pen Injectors
Dual Chambered Pen Injectors
By design

Tel No- 91 2241236650 / +91 - 998 729 5242
Standardized pen injectors

Customized pen injectors
By usability
Reusable
Disposable
Others (blunt-needle, micro needle, and nano needle injections)
Europe Injectable Drug Delivery Formulations Technologies, By Product

Conventional Drug Delivery Formulations
Solution
Reconstituted / Lyophilized Formulations
Novel Drug Delivery Formulations
Liposomal Systems
Microspheres
Nanoparticles
Polymeric Micelles
Others (dendrimers, nanosponge, and nanoemulsions)
Europe Injectable Drug Delivery Technologies Market, By Therapeutic Applications

Auto-immune Diseases
Multiple Sclerosis
Rheumatoid Arthritis

Tel No- 91 2241236650 / +91 - 998 729 5242
Crohns Diseases
Psoriasis
Others
Hormonal Disorders
Diabetes
Antithrombotic/Thrombolytic Therapy
Reproductive Health Diseases
Anemia
Osteoporosis
Others
Orphan Diseases
Oncology
Others
Pain Management
Allergies
Hepatitis C
Aesthetic Treatment
Europe Injectable Drug Delivery Technologies Market, By Geography

Germany
France
U.K.

Tel No- 91 2241236650 / +91 - 998 729 5242
Spain
Italy
Russia
Rest of Europe
Table of Contents
1 Introduction 26
1.1 Key Take-Aways 26
1.2 Report Description 26
1.3 Markets Covered 28
1.4 Stakeholders 31
1.5 Research Methodology 31
1.5.1 Market Size 31
1.5.2 Market Share 32
1.5.3 Key Data Points From Secondary Sources 32
1.5.4 Key Data Points From Primary Sources 32
1.5.5 Assumptions 33
2 Executive Summary 34
3 Market Overview 39
3.1 Introduction 40
3.2 Market Segmentation 44
3.3 Market Dynamics 46
3.3.1 Drivers 47
3.3.1.1 Technological Advancements 47
3.3.1.2 Favorable Reimbursement Environment To Bolster The Demand Of Self Injection Devices 48
3.3.1.3 Surge Of Biologics In European Pharmaceutical Market 49
3.3.1.4 Rising Incidences Of Cancer And Diabetes 50
3.3.1.5 Improving Patient Compliance 51
3.3.2 Restraints 52
3.3.2.1 Needle-Stick Injuries And Infections 52

Tel No- 91 2241236650 / +91 - 998 729 5242
3.3.2.2 Threat From Alternate Drug Delivery Methods 53

3.3.2.3 Slow Approval Process Of Drugs And Medical Devices In Europe 54
3.3.3 Opportunities 55
3.3.3.1 Development Of Biosimilars In The European Pharmaceutical Market 55
3.3.3.2 Need For Better Healthcare For The Increasing Geriatric Population Of Europe 56
3.3.4 Challenges 57
3.3.4.1 Sustainability Of Players In Highly Competitive Market 57
3.4 Market Share Analysis, By Major Players 58
3.4.1 Conventional Injectable Drug Delivery Devices 58
3.4.2 Self-Injection Devices-Pen Injectors 61
4 European Injectable Drug Delivery Devices Technologies Market 65

4.1 Introduction 66
4.2 Market Segmentation 70
4.3 Manufacturers Criteria For Selection Of An Injectable Device 71
4.4 Conventional Injectable Drug Delvery Devices 73
4.4.1 By Usability 75
4.4.1.1 Disposable 76
4.4.1.2 Reusable 78
4.4.2 By Material 79
4.4.2.1 Glass 80
4.4.2.2 Plastic 82
4.4.3 By Product 84
4.4.3.1 Fillable 85
4.4.3.2 Prefilled 86
4.5 Self-Injection Devices 88
4.5.1 Market Segmentation 91
4.5.2 Selection Criteria For Self-Injection Device 92
4.5.3 Pen Injectors 94
4.5.3.1 By Product 96
4.5.3.1.1 Single Chamber Pen Injectors 97
4.5.3.1.2 Dual Chamber Pen Injectors 99
4.5.3.2 By Usability 100

Tel No- 91 2241236650 / +91 - 998 729 5242
4.5.3.2.1 Disposable Pen Injectors 101

4.5.3.2.2 Reusable Pen Injectors 102
4.5.3.3 By Design 104
4.5.3.3.1 Standard Pen Injectors 104
4.5.3.3.2 Customized Pen Injectors 106
4.5.4 Needle-Free Injectors 107
4.5.4.1.1 Prefilled Needle Free Injectors 109
4.5.4.1.2 Fillable Needle Free Injectors 111
4.5.4.2 By Technology 112
4.5.4.2.1 Jet-Based Needle-Free Injectors 113
4.5.4.2.2 Spring-Based Needle-Free Injectors 115
4.5.4.2.3 Laser-Based Needle Free Injectors 116
4.5.4.2.4 Vibration-Based Needle Free Injectors 118
4.5.4.3.1 Disposable 119
4.5.4.3.2 Reusable 121
4.5.5 Auto Injectors 122
4.5.5.1.1 Prefilled Auto Injectors 124
4.5.5.1.2 Fillable Auto Injectors 126
4.5.5.2 By Technology 127
4.5.5.2.1 Automated Auto Injectors 128
4.5.5.2.2 Manual Auto Injectors 130
4.5.5.3 By Design 131
4.5.5.3.1 Standardized Auto Injectors 132
4.5.5.3.2 Customized Auto Injectors 133
4.5.5.4.1 Disposable Auto Injectors 136
4.5.5.4.2 Reusable Auto Injectors 137
4.6 Others 139
5 European Injectable Drug Delivery Formulation Technologies Market 141
5.1 Introduction 142

Tel No- 91 2241236650 / +91 - 998 729 5242
5.2 Conventional Drug Delivery 146

5.2.1 Injectable Solutions 148
5.2.2 Reconstituted/Lyophilized Formulations 150
5.3 Novel Drug Delivery Formulation Technologies 153
5.3.1 Market Segmentation 156
5.3.2 Liposomal Systems 157
5.3.3 Microspheres 159
5.3.4 Nanoparticles 161
5.3.5 Polymeric Micelles 163
5.3.6 Others 165
6 European Injectable Drug Delivery Technologies Market, By Therapeutic Applications 168
6.2 Auto-Immune Diseases 173
6.2.1 Multiple Sclerosis 176
6.2.2 Rheumatoid Arthritis 178
6.2.3 Crohns Diseases 181
6.2.4 Psoriasis 182
6.2.5 Others 184
6.3 Hormonal Disorders 186
6.3.1 Diabetes 189
6.3.2 Anemia 191
6.3.3 Reproductive Health Diseases 193
6.3.4 Antithrombotic/Thrombolytic Therapy 195
6.3.5 Osteoporosis 196
6.3.6 Growth Hormone Deficiency 198
6.4 Orphan/Rare Diseases 200
6.5 Oncology 203
6.6 Others 205
6.6.1 Pain Management 206
6.6.2 Hepatitis C 208
6.6.3 Allergies 210
6.6.4 Aesthetic Treatment 212

Tel No- 91 2241236650 / +91 - 998 729 5242
7 Geographic Analysis 215

7.2 Germany 217
7.2.1 More Than 25 New Medicines Are Due For Marketing License In Germany For The Year 2013 217
7.3 France 223
7.3.1 Higher Insurance Coverage, Increase In Aging Population And Affordability Drives The Market In
France 224
7.4 U.K. 228
7.4.1 Highest Turnover Of Antibiotics And Small Molecules Due To Oncology And Infections 229
7.4.2 Bioscience & Health Technology Database Provide Better Industry Data On Injectable Technologies
230
7.5 Spain 233
7.5.1 Spain Is Amongst The Top 10 Countries With Highest Expenditure On Diabetes 235
7.6 Italy 237
7.6.1 Removal Of Linkages Between Patent And Generic Medicines Causes Rapid Access To Generics In
Italy 238
7.7 Russia 241
7.7.1 Russian Government Aimed To Foster The Development Of Healthcare System 241
7.8 Rest Of Europe 246
7.8.1 Switzerland Has The Most Competitive Economy And Has Leading Position In Global
Pharmaceuticals And Biotech Industries 246
7.8.2 Denmark Provides For Concentrated Patient Pool Especially For Diabetes Due To Centralization Of
Healthcare System 247
7.8.3 High Acceptability For New Technologies And Lowest Corporate Tax Rate Drives The Ireland
Market 249
7.8.4 Favorable Growth In Regions Of Portugal, Poland, And Romania Due To Increasing Diabetes
Incidence And Related Reimbursement Policies 250
8 Competitive Landscape 251
8.2 Expansion 254
8.3 Agreements, Partnerships, Collaborations & Joint Ventures 260
8.4 New Product Launch 265

Tel No- 91 2241236650 / +91 - 998 729 5242
8.5 Mergers & Acquisitions 269

8.6 Other Developments 272
9 Company Profiles 277
(Overview, Financials, Products & Services, Strategy, & Developments)*
9.1 Alkermes, Inc. 277
9.2 Bespak Europe, Ltd.
(Subsidiary Of Consort Medical, Plc) 283
9.3 Crossject 288
9.4 Gerresheimer Ag 291
9.5 Haselmeier Gmbh 297
9.6 Injex Pharma Gmbh
(Subsidiary Of Hns International, Inc.) 300
9.7 Novo Nordisk A/S 304
9.8 Owen Mumford, Ltd. 310
9.9 Sanofi 313
9.10 Schott Ag 318
9.11 Vetter Pharma-Fertigung Gmbh & Co. Kg 323
9.12 Ypsomed Holding Ag 326
*Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of
Unlisted Companies.
List Of Tables
Table 1 Europe Injectable Drug Delivery Technologies Market,
By Segment, 2010 - 2017 ($Million) 36
By Segment, 2010 - 2017 ($Million) 41
Table 3 Injection Drug Delivery Technologies Market, By Geography, 2010 - 2017 ($Million) 43
Table 4 Europe Injectable Drug Delivery Devices Technologies Market, By Product, 2010 - 2017
($Million) 67
Table 5 Injection Drug Delivery Devices Technologies Market,

Tel No- 91 2241236650 / +91 - 998 729 5242
By Geography, 2010 - 2017 ($Million) 68

Table 6 Conventional Injection Devices Market, By Geography,
2010 - 2017 ($Million) 74
Table 7 European Conventional Injection Devices Market,
By Usability, 2010 - 2017 ($Million) 76
Table 8 Disposable Conventional Devices Market, By Geography,
2010 - 2017 ($Million) 77
Table 9 Reusable Conventional Devices Market, By Geography,
2010 - 2017 ($Million) 78
By Material, 2010 - 2017 ($Million) 79
Table 11 Conventional Injection Devices (Glass) Market,
Table 12 Conventional Injection Devices (Plastic) Market,
By Product, 2010 - 2017 ($Million) 84
Table 14 Fillable Conventional Injection Devices Market,
Table 15 Prefilled Conventional Injection Devices Market,
Table 16 Major Therapeutic Areas For Self-Injection Devices 88

Tel No- 91 2241236650 / +91 - 998 729 5242
Table 17 Europe Self-Injection Devices Market, By Product,

2010 - 2017 ($Million) 89
Table 18 Self-Injection Devices Market, By Geography,
2010 - 2017 ($Million) 90
Table 19 Pen Injector Market, By Geography, 2010 - 2017 ($Million) 95
Table 20 European Pen Injectors Market, By Product,
2010 - 2017 ($Million) 97
Table 21 Single Chamber Pen Injector Market, By Geography,
2010 - 2017 ($Million) 98
Table 22 Dual Chamber Pen Injector Market, By Geography,
2010 - 2017 ($Million) 99
Table 23 European Pen Injectors Market, By Usability,
2010 - 2017 ($Million) 100
Table 24 Disposable Pen Injectors Market, By Geography,
2010 - 2017 ($Million) 101
Table 25 Reusable Pen Injectors Market, By Geography,
2010 - 2017 ($Million) 103
Table 26 European Pen Injectors Market, By Design,
2010 - 2017 ($Million) 104
Table 27 Standard Pen Injectors Market, By Geography,
2010 - 2017 ($Million) 105
Table 28 Customized Pen Injectors Market, By Geography,

Tel No- 91 2241236650 / +91 - 998 729 5242
2010 - 2017 ($Million) 106

Table 29 Needle Free Injectors Market, By Geography,
2010 - 2017 ($Million) 108
Table 30 European Needle Free Injectors Market, By Product,
2010 - 2017 ($Million) 109
Table 31 Prefilled Needle Free Injectors Market, By Geography,
2010 - 2017 ($Million) 110
Table 32 Fillable Needle Free Injectors Market, By Geography,
2010 - 2017 ($Million) 111
Table 33 European Needle Free Injectors Market, By Technology,
2010 - 2017 ($Million) 112
Table 34 Jet-Based Needle Free Injector Market, By Geography,
2010 - 2017 ($Million) 114
Table 35 Spring-Based Needle Free Injector Market, By Geography, 2010 - 2017 ($Million) 115
Table 36 Laser-Powered Needle Free Injector Market, By Geography, 2010 - 2017 ($Million) 117
Table 37 Vibration-Based Needle Free Injector Market, By Geography, 2010 - 2017 ($Million) 118
Table 38 Europe Needle Free Injectors Market, By Usability,
2010 - 2017 ($Million) 119
Table 39 Disposable Needle Free Injectors Market, By Geography,
2010 - 2017 ($Million) 120
Table 40 Reusable Needle Free Injectors Market, By Geography,
2010 - 2017 ($Million) 121

Tel No- 91 2241236650 / +91 - 998 729 5242
Table 41 Auto Injectors Products Market, By Geography,

2010 - 2017 ($Million) 123
Table 42 Europe Auto Injectors Market, By Product,
2010 - 2017 ($Million) 124
Table 43 Prefilled Auto Injectors Market, By Geography,
2010 - 2017 ($Million) 125
Table 44 Fillable Auto Injectors Market, By Geography,
2010 - 2017 ($Million) 126
Table 45 Europe Auto Injectors Market, By Technology,
2010 - 2017 ($Million) 127
Table 46 Automated Auto Injectors Market, By Geography,
2010 - 2017 ($Million) 129
Table 47 Manual Auto Injectors Market, By Geography,
2010 - 2017 ($Million) 130
Table 48 Europe Auto Injectors Market, By Design,
2010 - 2017 ($Million) 131
Table 49 Standardized Auto Injectors Market, By Geography,
2010 - 2017 ($Million) 132
Table 50 Customized Auto Injectors Auto Injectors Market,
Table 51 Europe Auto Injectors Market, By Usability,
2010 - 2017 ($Million) 135

Tel No- 91 2241236650 / +91 - 998 729 5242
Table 52 Disposable Auto Injectors Market, By Geography,

2010 - 2017 ($Million) 136
Table 53 Reusable Auto Injectors Market, By Geography,
2010 - 2017 ($Million) 138
Table 54 Others Injectors Market, By Geography,
2010 - 2017 ($Million) 139
Table 55 Europe Injectable Drug Delivery Formulation Technologies Market, By Segment, 2010 - 2017
($Million) 142
Table 56 Injectable Drug Delivery Formulation Technologies Market, By Geography, 2010 - 2017
($Million) 144
Table 57 Europe Conventional Drug Delivery Formulation Technologies Market, 2010 - 2017 ($Million)
147
Table 58 Conventional Drug Delivery Formulation Technologies Market, By Geography, 2010 - 2017
($Million) 148
Table 59 Injectable Solutions Conventional Drug Delivery Formulation Market, By Geography, 2010 2017 ($Million) 149
Table 60 Reconstituted/Lyophilized Conventional Drug Delivery Formulation Market, By Geography,
2010 - 2017 ($Million) 151
Table 61 Novel Drug Delivery Formulation Technologies Market,
2010 - 2017 ($Million) 153
Table 62 Novel Drug Delivery Formulation Technologies Market,
Table 63 Liposome Drug Delivery Formulation Market, By Geography, 2010 - 2017 ($Million) 158
Table 64 Microspheres Drug Delivey Formulation Market,

Tel No- 91 2241236650 / +91 - 998 729 5242

Table 65 Nanoparticles Drug Delivey Formulation Market,
Table 66 Polymeric Micelles Drug Delivey Formulation Market,
Table 67 Other Novel Drug Delivey Formulation Market, By Geography, 2010 - 2017 ($Million) 166
By Therapeutic Application, 2010 - 2017 ($Million) 169
Table 69 Europeauto-Immune Therapeutic Market, By Indication,
2010 - 2017 ($Million) 174
Table 70 Auto-Immune Therapeutic Market,By Geography,
2010 - 2017 ($Million) 175
Table 71 Multiple Sclerosis Market, By Geography,
2010 - 2017 ($Million) 177
Table 72 Rheumatoid Arthritis Market, By Geography,
2010 - 2017 ($Million) 179
Table 73 Crohns Diseases Market, By Geography,
2010 - 2017 ($Million) 181
Table 74 Psoriasis Market, By Geography, 2010 - 2017 ($Million) 183
Table 75 Other Auto-Immune Diseases Market, By Geography,
2010 - 2017 ($Million) 185
Table 76 Europe Hormonal Disorders, By Indication,

Tel No- 91 2241236650 / +91 - 998 729 5242
2010 - 2017 ($Million) 187

Table 77 Hormonal Disorders Market, By Geography,
2010 - 2017($Million) 188
Table 78 Diabetes Market, By Geography, 2010 - 2017 ($Million) 189
Table 79 Anemia Market, By Geography, 2010 - 2017 ($Million) 191
Table 80 Reproductive Health Diseases Market, By Geography,
2010 - 2017($Million) 193
Table 81 Antithrombotic Therapy Market, By Geography,
2010 - 2017 ($Million) 195
Table 82 Osteoporosis Market, By Geography, 2010 - 2017 ($Million) 197
Table 83 Growth Hormone Deficiency Market, By Geography,
2010 - 2017 ($Million) 199
Table 84 Orphan/Rare Diseases Therapeutic Market, By Geography, 2010 - 2017 ($Million) 201
Table 85 Oncology Therapeutic Market, By Geography,
2010 - 2017 ($Million) 203
Table 86 European Other Therapeutic Market, 2010 - 2017 ($Million) 205
Table 87 Other Therapeutic Market, By Geography,
2010 - 2017 ($Million) 206
Table 88 Pain Management Market, By Geography, 2010 - 2017 ($Million) 207
Table 89 Hepatitis C Market, By Geography, 2010 - 2017 ($Million) 209
Table 90 Allergies/Anaphylytic Shock Market, By Geography,
2010 - 2017 ($Million) 211

Tel No- 91 2241236650 / +91 - 998 729 5242
Table 91 Aesthetic Treatment Market, By Geography,

2010 - 2017 ($Million) 213
Table 92 Germany: Injectable Drug Delivery Technologies Market, 2010 - 2017 ($Million) 218
Table 93 Germany: Injectable Drug Delivery Devices Technologies Market, By Segment, 2010 - 2017
($Million) 219
Table 94 Germany: Injectable Drug Delivery Formulation Technologies Market, 2010 - 2017 ($Million)
221
Table 95 Germany: Injectable Drug Delivery Technologies Market,
Table 96 France: Injectable Drug Delivery Technologies Market,
2010 - 2017 ($Million) 224
Table 97 France: Injectable Drug Delivery Devices Technologies Market, By Segment, 2010 - 2017
($Million) 225
Table 98 France: Injectable Drug Delivery Formulation Technologies Market, 2010 - 2017 ($Million) 226
Table 99 France: Injectable Drug Delivery Technologies Market,
By Therapeutic Application 2010 - 2017 ($Million) 227
Table 100 U.K.: Injectable Drug Delivery Technologies Market,
2010 - 2017 ($Million) 228
Table 101 U.K.: Injectable Drug Delivery Devices Technologies Market, By Segment, 2010 - 2017
($Million) 229
Table 102 U.K.: Injectable Drug Delivery Formulation Technologies Market, 2010 - 2017 ($Million) 230
Table 103 U.K.: Injectable Drug Delivery Technologies Market,

Tel No- 91 2241236650 / +91 - 998 729 5242
Table 104 Spain: Injectable Drug Delivery Technologies Market,

2010 - 2017 ($Million) 233
Table 105 Spain: Injectable Drug Delivery Devices Technologies Market, By Segment, 2010 - 2017
($Million) 234
Table 106 Spain: Injectable Drug Delivery Formulation Technologies Market, 2010 - 2017 ($Million) 235
Table 107 Spain: Injectable Drug Delivery Technologies Market,
Table 108 Italy: Injectable Drug Delivery Technologies Market,
2010 - 2017 ($Million) 237
Table 109 Italy: Injectable Drug Delivery Devices Technologies Market, By Segment, 2010 - 2017
($Million) 238
Table 110 Italy: Injectable Drug Delivery Formulation Technologies Market, 2010 - 2017 ($Million) 239
Table 111 Italy: Injectable Drug Delivery Technologies Market,
Table 112 Russia: Injectable Drug Delivery Technologies Market,
2010 - 2017 ($Million) 242
Table 113 Russia: Injectable Drug Delivery Devices Technologies Market, By Segment, 2010 - 2017
($Million) 243
Table 114 Russia: Injectable Drug Delivery Formulation Technologies Market, 2010 - 2017 ($Million) 244
Table 115 Russia: Injectable Drug Delivery Technologies Market,
Table 116 Roe: Injectable Drug Delivery Technologies Market,
2010 - 2017 ($Million) 246

Tel No- 91 2241236650 / +91 - 998 729 5242
Table 117 Roe: Injectable Drug Delivery Devices Technologies Market, By Segment, 2010 - 2017
($Million) 247
Table 118 Roe: Injectable Drug Delivery Formulation Technologies Market, 2010 - 2017 ($Million) 248
Table 119 Roe: Injectable Drug Delivery Technologies Market,
Table 120 Expansion, 2010 - 2013 255
Table 121 Agreements, Partnerships, Collaborations & Joint Ventures, 2010 - 2013 261
Table 122 New Product Launch, 2010 - 2013 266
Table 123 Mergers & Acquisitions, 2010 - 2013 270
Table 124 Other Developments, 2010 - 2013 272
Table 125 Alkermes: Total Revenue And R&D Expenses,
2009 - 2011 ($Million) 278
Table 126 Alkermes: Total Revenue, By Geography, 2009 - 2011 ($Million) 278
Table 127 Consort Medical: Total Revenue And R&D Expense,
2009 - 2011 ($Million) 284
Table 128 Consort Medical: Total Revenue, By Geography,
2009 - 2011 ($Million) 284
Table 129 Gerresheimer Ag: Total Revenue And R&D Expenses,
2010 - 2012 ($Million) 292
Table 130 Gerresheimer Ag: Total Revenue, By Segment,
2010 - 2012 ($Million) 292
Table 131 Gerresheimer Ag: Total Revenue, By Geography,

Tel No- 91 2241236650 / +91 - 998 729 5242
2010 - 2012 ($Million) 293

Table 132 Novo Nordisk: Total Revenue And R&D Expenses,
2010 - 2012 ($Billion) 305
Table 133 Novo Nordisk: Total Revenue, By Segment,
2010 - 2012 ($Billion) 305
Table 134 Novo Nordisk: Total Revenue, By Geography,
2010 - 2012 ($Billion) 306
Table 135 Sanofi: Total Revenue & R&D Expenditure,
2010 - 2012 ($Billion) 314
Table 136 Sanofi: Total Revenue, By Segment, 2010 - 2012 ($Billion) 314
Table 137 Sanofi: Total Revenue, By Geography, 2010 - 2012 ($Billion) 315
Table 138 Schott Ag: Total Revenue And R&D Expenditures,
2010 - 2012 ($Million) 319
Table 139 Schott Ag: Total Revenue, By Geography,
2010 - 2012 ($Million) 319
Table 140 Ypsomed: Total Revenue And R&D Expenses,
2009 - 2011 ($Million) 327
Table 141 Ypsomed: Total Revenue, By Segment, 2009 - 2011 ($Million) 327
Table 142 Ypsomed: Total Revenue, By Geography, 2009 ($Million) 328
Table 143 Ypsomed: Total Revenue, By Geography, 2010 - 2011 ($Million) 328
List Of Figures
Figure 1 Europe Injectable Drug Delivery Technologies Market,

Tel No- 91 2241236650 / +91 - 998 729 5242
By Segment, 2012 & 2017 35

Figure 2 Injectable Drug Delivery Technologies Market,
By Geography, 2012 37
Figure 3 Injectable Drug Delivery Technologies Market Segmentation 40
Figure 4 Injectable Drug Delivery Technologies Market Segmentation 44
Figure 5 Market Segmentation Of Injectable Drug Delivery Technologies, By Therapeutic Application 45
Figure 6 Injectable Drug Delivery Technologies Market Dynamics 46
Figure 7 Europeconventional Injection Devices Market,
By Key Players, 2012 ($Million) 58
Figure 8 European Pen Injectors Market, By Key Players,
2012 ($Million) 62
Figure 9 Injectable Drug Delivery Devices Technologies Market Segmentation 70
Figure 10 Factors Affecting Selection Of An Injectable Device 71
Figure 11 European Self-Injection Devices Market, By Product,
2010 - 2017 ($Million) 91
Figure 12 Self-Injection Devices Market Segmentation 91
Figure 13 Factors Affecting Selection Of Self-Injection Device 92
Figure 14 Conventional Drug Delivery Formulation Technologies Market Segmentation 146
Figure 15 Europe Novel Drug Delivey Formulation Market,
2012 & 2017 ($Million) 154
Figure 16 Novel Drug Delivery Formulation Technologies Segmentation 157
Figure 17 Europe Injectable Drug Delivery Technologies Market,

Tel No- 91 2241236650 / +91 - 998 729 5242

Figure 18 Injectable Drug Delivery Technologies Market Segmentation, By Therapeutic Applications 172
Figure 19 Auto-Immune Therapeutic Market Segmentation 173
Figure 20 Hormonal Disorders Market Segmentation 186
Figure 21 Key Growth Strategies, 2010 - 2013 251
Figure 22 Key Growth Strategies, By Companies, 2010 - 2013 253
Figure 23 Geographical Expansions, By Company, 2010 - 2013 254
Figure 24 Agreements, Partnerships, Collaborations & Joint Ventures, By Company, 2010 - 2013 260
Figure 25 New Product Launch, By Company, 2010 - 2013 265
Figure 26 Mergers & Acquisitions, By Company, 2010 - 2013 269
Product Price :
License Type
Price
PDF
$ 4650
Multi User Licence
$ 5650
Corporate Licence
$ 7150
Enterprise Wide Licence
$ 9000

Tel No- 91 2241236650 / +91 - 998 729 5242
Related reports:
The Market for Stem Cell Biobanking and Storage - Size, Segments, and Trends
Genotyping Market by Technology (Polymerase Chain Reaction, Sequencing, Microarray,
Electrophoresis, MALDI_TOF), Application (Pharmacogenomics, Diagnostic Research, Animal
Genetics, Agricultural Biotechnology) & by Products - Global Forecast to 2020
EMR/EHR Market in the US 2015-2019
Global Capsule Endoscopes Market 2015-2019
Global Diabetic Retinopathy Market 2015-2019
Global Hemodialysis Market 2015-2019
Global Medical Laser Systems Market 2015-2019
Global Peripheral Vascular Devices Market 2015-2019
Healthcare IT Market in Saudi Arabia 2015-2019
Mycoplasma Testing Market by Products (Instruments, Kits & Reagents, Services), Application (Cell
Line, Virus, End of Production Cells), Technology (PCR, ELISA, Direct Assay), End User (Cell
Banks, Pharmaceutical Companies) - Global Forecast to 2019
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at
contact@jsbmarketresearch.com

Tel No- 91 2241236650 / +91 - 998 729 5242
About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is one-stop-shop for
all information related to market research for any sector of the industry. Along with providing in-depth
analysis though reports, JSB market research also provides regular updates of the market though
newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and
a good level of market experience.
To know more on European Injectable Drug Delivery Market By Formulations [Liposomes,

Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle
Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Forecasts to 2017
http://www.jsbmarketresearch.com/healthcare-medical/r-european-injectable-drug-delivery-marketby-formulations-devices-173996

Tel No- 91 2241236650 / +91 - 998 729 5242

Released On 27 May February 2015: Injectable Drug Delivery

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Released On 27 May February 2015: Injectable Drug Delivery

Uploaded by

Copyright:

Available Formats

European Injectable Drug Delivery Market By Formulations [Liposomes,

Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable &

Email ID- contact@jsbmarketresearch.com

Browse complete Report on:

Europe Injectable Drug Delivery Technologies Market, By Segment

JSB Market Research Pvt. Ltd.

Email ID- contact@jsbmarketresearch.com

Europe Injectable Drug Delivery Devices Technologies Market, By Product

Email ID- contact@jsbmarketresearch.com

Email ID- contact@jsbmarketresearch.com

Standardized pen injectors

Europe Injectable Drug Delivery Formulations Technologies, By Product

Europe Injectable Drug Delivery Technologies Market, By Therapeutic Applications

Email ID- contact@jsbmarketresearch.com

Europe Injectable Drug Delivery Technologies Market, By Geography

Email ID- contact@jsbmarketresearch.com

Email ID- contact@jsbmarketresearch.com

3.3.2.2 Threat From Alternate Drug Delivery Methods 53

4 European Injectable Drug Delivery Devices Technologies Market 65

Email ID- contact@jsbmarketresearch.com

4.5.3.2.1 Disposable Pen Injectors 101

Email ID- contact@jsbmarketresearch.com

5.2 Conventional Drug Delivery 146

Email ID- contact@jsbmarketresearch.com

7 Geographic Analysis 215

Email ID- contact@jsbmarketresearch.com

8.5 Mergers & Acquisitions 269

Email ID- contact@jsbmarketresearch.com

By Geography, 2010 - 2017 ($Million) 68

Email ID- contact@jsbmarketresearch.com

Table 17 Europe Self-Injection Devices Market, By Product,

Email ID- contact@jsbmarketresearch.com

2010 - 2017 ($Million) 106

Email ID- contact@jsbmarketresearch.com

Table 41 Auto Injectors Products Market, By Geography,

Email ID- contact@jsbmarketresearch.com

Table 52 Disposable Auto Injectors Market, By Geography,

Email ID- contact@jsbmarketresearch.com

By Geography, 2010 - 2017 ($Million) 160

Email ID- contact@jsbmarketresearch.com

2010 - 2017 ($Million) 187

Email ID- contact@jsbmarketresearch.com

Table 91 Aesthetic Treatment Market, By Geography,

Email ID- contact@jsbmarketresearch.com

Table 104 Spain: Injectable Drug Delivery Technologies Market,

Email ID- contact@jsbmarketresearch.com

Email ID- contact@jsbmarketresearch.com

2010 - 2012 ($Million) 293

Email ID- contact@jsbmarketresearch.com

By Segment, 2012 & 2017 35

Email ID- contact@jsbmarketresearch.com

By Therapeutic Application, 2010 - 2017 ($Million) 171

Multi User Licence

Enterprise Wide Licence

JSB Market Research Pvt. Ltd.

Email ID- contact@jsbmarketresearch.com

JSB Market Research Pvt. Ltd.

Email ID- contact@jsbmarketresearch.com

To know more on European Injectable Drug Delivery Market By Formulations [Liposomes,

JSB Market Research Pvt. Ltd.

Email ID- contact@jsbmarketresearch.com

You might also like